Lenz Therapeutics Inc (LENZ) - News Archive

In a significant development for the biotechnology sector, LENZ Therapeutics Inc. has announced an exclusive licensing and commercialization agreement with Laboratoires Tha for its innovative therapeutic candidate LNZ10...

In a significant development within the pharmaceutical sector, LENZ Therapeutics has announced an exclusive licensing and commercialization agreement with Lotus Pharmaceutical for its novel product, LNZ100, in the Repub...

In a significant milestone for the field of ophthalmology, SAN DIEGO-based LENZ Therapeutics, Inc. (Nasdaq: LENZ), has announced a major development that promises to bring transformative change to millions. As of August...

LENZ Therapeutics Enhances Tangible Leverage Ratio and Secures $30 Million Investment from Ridgeback CapitalSAN DIEGO, July 15, 2024 - LENZ Therapeutics, Inc. (Nasdaq: LENZ or LENZ or the Company), a late clinical-stage...